Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-06-08

Clinical Trial Update: Preterm Delivery Risk Prediction by Measurement of Prenatal Serum Screening Markers

View source ↗

Summary

This clinical trial update describes research into predicting preterm birth risk by measuring prenatal serum screening markers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Esoterix Genetic Laboratories, LLC | Conditions: Preterm Delivery | Status: UNKNOWN